EVOXAC 30 mg (Evoxac 30 mg)
Generic Name: cevimeline
Pill imprint EVOXAC 30 mg has been identified as Evoxac 30 mg.
Evoxac is used in the treatment of sjogren's syndrome and belongs to the drug class cholinergic agonists. Risk cannot be ruled out during pregnancy. Evoxac 30 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- EVOXAC 30 mg
- 30 mg
- 15.00 mm
- Prescription only
- Drug Class:
- Cholinergic agonists
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Daiichi Sankyo, Inc.
- National Drug Code (NDC):
|NDC Code||Manufacturer / Repackager|
|63304-0479||Ranbaxy Pharmaceuticals Inc.|
|66267-1298||Nucare Pharmaceuticals Inc (repackager)|
|16590-0859||Stat RX USA LLC (repackager)|
Note: Inactive ingredients may vary.
More about Evoxac (cevimeline)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.